SCHEMBL25782641

SCHEMBL25782641

CC(C)(C)c1cccc(P(=O)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.47
▸ RXRA P19793 1/20 0.45
▸ RXRB P28702 1/20 0.45
▸ PGK1 P00558 1/20 0.43
▸ PGK2 P07205 1/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ KIF11 P52732 1/20 0.42
▸ ACHE P22303 3/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ PTPN5 P54829 1/20 0.40
▸ NR1H4 Q96RI1 1/20 0.39
▸ KCNK9 Q9NPC2 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15698253 0.90 NPSR1 (0.45) NPSR1PGK1PGK2LMNAPTPN1
SCHEMBL22314656 0.86 NR1H4 (0.43) NPSR1RXRARXRBPGK1PGK2
SCHEMBL26077627 0.83 RXRA (0.43) NPSR1RXRARXRBHDAC8LMNA
SCHEMBL17994314 0.82 LMNA (0.41) NPSR1LMNAKIF11PTPN1KCNK9
SCHEMBL17994301 0.82 LMNA (0.50) NPSR1LMNAKCNK9TSHRALDH1A1
SCHEMBL31212638 0.82 LMNA (0.50) NPSR1LMNAKCNK9TSHRALDH1A1
SCHEMBL18118552 0.81 PTPN1 (0.41) NPSR1LMNAKIF11PTPN1KCNK9
SCHEMBL8164654 0.81 PGK1 (0.51) PGK1PGK2LMNAKIF11PTPN1
SCHEMBL9609573 0.80 HDAC8 (0.46) NPSR1RXRARXRBPGK1PGK2
SCHEMBL13810745 0.80 NPSR1 (0.41) NPSR1RXRARXRBPGK1PGK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11700768-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-07-11 — — US disclosed
US-11700768-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11700768-B2 Compound and organic light emitting device comprising the same ARL1, ARRB1, CRY1 NPSR1 2926/4885RXRA 657/4885RXRB 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback